A researcher at the University of Birmingham has been named Young Investigator of the Year by the British Neuro-Oncology Society.
University of Birmingham scientists are among more than 100 experts who have signed a letter published in The Lancet urging the UK Government to reconsider its plans to abandon all COVID-19 restrictions.
A new clinical trial being sponsored by the University of Birmingham has opened for recruitment aiming to investigate the efficacy of a novel treatment for patients affected by a specific type of blood cancer.
Dr Lennard Lee, Academic Clinical Lecturer at the University of Oxford/Honorary Research Fellow at the University of Birmingham, has been awarded the 2020 Association of Cancer Physicians (ACP) McElwain Prize.
A University of Birmingham-led study has found that almost half of patients with inoperable pancreatic cancer are not prescribed essential medication.
NEC Laboratories Europe has agreed to donate to the Birmingham Institute of Head and Neck Studies and Education (InHANSE) to support its future cancer research.
Funding from Bayer enables the University of Birmingham to deliver a new study aiming to identify more effective treatments for a rare type of childhood cancer.
The University of Birmingham is part of a new industry collaboration to accelerate drug discovery projects that will fast track research from lab to patient.
Work is set to begin on the first phase of Birmingham Health Innovation Campus this Summer after planning permission was granted by Birmingham City Council.
A new project has been launched in collaboration with the University of Birmingham aimed at aiding more precise drug dosing in children with cancer.